CRBP-1 expression in ovarian cancer: A potential therapeutic target

Elena Doldo, Gaetana Costanza, Amedeo Ferlosio, Daniela Passeri, Sergio Bernardini, Maria Giovanna Scioli, Donatella Mazzaglia, Sara Agostinelli, Donatella Del Bufalo, Bernard Czernobilsky, Augusto Orlandi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/Aim: Cellular retinol binding protein-1 regulates retinol bioavailability and contributes to cell differentiation maintenance, but its role in ovarian carcinogenesis remains uncertain. We investigated CRBP-1 expression in ovarian tumors and CRBP-1 signaling-regulated pathways. Materials and Methods: We performed immunohistochemistry, methylation-specific PCR, gene copy number analysis in ovarian tumors and proliferation/apoptosis evaluation, gene array, blot and real-time PCR in CRBP-1-transfected A2780 ovarian cancer cells. Results: CRBP-1 expression was reduced or absent in G2 and G3 ovarian carcinomas. CRBP-1 silencing in 60% of G2 and 66.7% of G3 carcinomas was due to CRBP-1 promoter methylation. A2780 CRBP-1-transfected cells showed increased retinol-induced apoptosis, retinoid-induced reduced clonogenicity and down-regulation of proliferation and transcription genes, including AKT1, AKT3, EGFR, FOS, JUN, STAT1 and STAT5A. Conclusion: CRBP-1 loss in G2/G3 ovarian carcinomas and increased apoptotic susceptibility to retinoids in CRBP-1-transfected-A2780 cells suggest CRBP-1 screening as a target to ensure efficacy of an adjuvant retinoid therapy.

Original languageEnglish
Pages (from-to)3303-3312
Number of pages10
JournalAnticancer Research
Volume34
Issue number7
Publication statusPublished - Jul 1 2014

Fingerprint

Retinoids
Ovarian Neoplasms
Carcinoma
Vitamin A
Methylation
Cellular Retinol-Binding Proteins
Apoptosis
Gene Dosage
Biological Availability
Genes
Real-Time Polymerase Chain Reaction
Cell Differentiation
Neoplasms
Carcinogenesis
Therapeutics
Down-Regulation
Immunohistochemistry
Maintenance
Polymerase Chain Reaction

Keywords

  • Apoptosis
  • Gynecological cancer
  • Ovarian tumor
  • Retinol
  • Retinol binding protein

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Doldo, E., Costanza, G., Ferlosio, A., Passeri, D., Bernardini, S., Scioli, M. G., ... Orlandi, A. (2014). CRBP-1 expression in ovarian cancer: A potential therapeutic target. Anticancer Research, 34(7), 3303-3312.

CRBP-1 expression in ovarian cancer : A potential therapeutic target. / Doldo, Elena; Costanza, Gaetana; Ferlosio, Amedeo; Passeri, Daniela; Bernardini, Sergio; Scioli, Maria Giovanna; Mazzaglia, Donatella; Agostinelli, Sara; Del Bufalo, Donatella; Czernobilsky, Bernard; Orlandi, Augusto.

In: Anticancer Research, Vol. 34, No. 7, 01.07.2014, p. 3303-3312.

Research output: Contribution to journalArticle

Doldo, E, Costanza, G, Ferlosio, A, Passeri, D, Bernardini, S, Scioli, MG, Mazzaglia, D, Agostinelli, S, Del Bufalo, D, Czernobilsky, B & Orlandi, A 2014, 'CRBP-1 expression in ovarian cancer: A potential therapeutic target', Anticancer Research, vol. 34, no. 7, pp. 3303-3312.
Doldo E, Costanza G, Ferlosio A, Passeri D, Bernardini S, Scioli MG et al. CRBP-1 expression in ovarian cancer: A potential therapeutic target. Anticancer Research. 2014 Jul 1;34(7):3303-3312.
Doldo, Elena ; Costanza, Gaetana ; Ferlosio, Amedeo ; Passeri, Daniela ; Bernardini, Sergio ; Scioli, Maria Giovanna ; Mazzaglia, Donatella ; Agostinelli, Sara ; Del Bufalo, Donatella ; Czernobilsky, Bernard ; Orlandi, Augusto. / CRBP-1 expression in ovarian cancer : A potential therapeutic target. In: Anticancer Research. 2014 ; Vol. 34, No. 7. pp. 3303-3312.
@article{76f180c0654e4e498d0a8598c365cdb5,
title = "CRBP-1 expression in ovarian cancer: A potential therapeutic target",
abstract = "Background/Aim: Cellular retinol binding protein-1 regulates retinol bioavailability and contributes to cell differentiation maintenance, but its role in ovarian carcinogenesis remains uncertain. We investigated CRBP-1 expression in ovarian tumors and CRBP-1 signaling-regulated pathways. Materials and Methods: We performed immunohistochemistry, methylation-specific PCR, gene copy number analysis in ovarian tumors and proliferation/apoptosis evaluation, gene array, blot and real-time PCR in CRBP-1-transfected A2780 ovarian cancer cells. Results: CRBP-1 expression was reduced or absent in G2 and G3 ovarian carcinomas. CRBP-1 silencing in 60{\%} of G2 and 66.7{\%} of G3 carcinomas was due to CRBP-1 promoter methylation. A2780 CRBP-1-transfected cells showed increased retinol-induced apoptosis, retinoid-induced reduced clonogenicity and down-regulation of proliferation and transcription genes, including AKT1, AKT3, EGFR, FOS, JUN, STAT1 and STAT5A. Conclusion: CRBP-1 loss in G2/G3 ovarian carcinomas and increased apoptotic susceptibility to retinoids in CRBP-1-transfected-A2780 cells suggest CRBP-1 screening as a target to ensure efficacy of an adjuvant retinoid therapy.",
keywords = "Apoptosis, Gynecological cancer, Ovarian tumor, Retinol, Retinol binding protein",
author = "Elena Doldo and Gaetana Costanza and Amedeo Ferlosio and Daniela Passeri and Sergio Bernardini and Scioli, {Maria Giovanna} and Donatella Mazzaglia and Sara Agostinelli and {Del Bufalo}, Donatella and Bernard Czernobilsky and Augusto Orlandi",
year = "2014",
month = "7",
day = "1",
language = "English",
volume = "34",
pages = "3303--3312",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - CRBP-1 expression in ovarian cancer

T2 - A potential therapeutic target

AU - Doldo, Elena

AU - Costanza, Gaetana

AU - Ferlosio, Amedeo

AU - Passeri, Daniela

AU - Bernardini, Sergio

AU - Scioli, Maria Giovanna

AU - Mazzaglia, Donatella

AU - Agostinelli, Sara

AU - Del Bufalo, Donatella

AU - Czernobilsky, Bernard

AU - Orlandi, Augusto

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Background/Aim: Cellular retinol binding protein-1 regulates retinol bioavailability and contributes to cell differentiation maintenance, but its role in ovarian carcinogenesis remains uncertain. We investigated CRBP-1 expression in ovarian tumors and CRBP-1 signaling-regulated pathways. Materials and Methods: We performed immunohistochemistry, methylation-specific PCR, gene copy number analysis in ovarian tumors and proliferation/apoptosis evaluation, gene array, blot and real-time PCR in CRBP-1-transfected A2780 ovarian cancer cells. Results: CRBP-1 expression was reduced or absent in G2 and G3 ovarian carcinomas. CRBP-1 silencing in 60% of G2 and 66.7% of G3 carcinomas was due to CRBP-1 promoter methylation. A2780 CRBP-1-transfected cells showed increased retinol-induced apoptosis, retinoid-induced reduced clonogenicity and down-regulation of proliferation and transcription genes, including AKT1, AKT3, EGFR, FOS, JUN, STAT1 and STAT5A. Conclusion: CRBP-1 loss in G2/G3 ovarian carcinomas and increased apoptotic susceptibility to retinoids in CRBP-1-transfected-A2780 cells suggest CRBP-1 screening as a target to ensure efficacy of an adjuvant retinoid therapy.

AB - Background/Aim: Cellular retinol binding protein-1 regulates retinol bioavailability and contributes to cell differentiation maintenance, but its role in ovarian carcinogenesis remains uncertain. We investigated CRBP-1 expression in ovarian tumors and CRBP-1 signaling-regulated pathways. Materials and Methods: We performed immunohistochemistry, methylation-specific PCR, gene copy number analysis in ovarian tumors and proliferation/apoptosis evaluation, gene array, blot and real-time PCR in CRBP-1-transfected A2780 ovarian cancer cells. Results: CRBP-1 expression was reduced or absent in G2 and G3 ovarian carcinomas. CRBP-1 silencing in 60% of G2 and 66.7% of G3 carcinomas was due to CRBP-1 promoter methylation. A2780 CRBP-1-transfected cells showed increased retinol-induced apoptosis, retinoid-induced reduced clonogenicity and down-regulation of proliferation and transcription genes, including AKT1, AKT3, EGFR, FOS, JUN, STAT1 and STAT5A. Conclusion: CRBP-1 loss in G2/G3 ovarian carcinomas and increased apoptotic susceptibility to retinoids in CRBP-1-transfected-A2780 cells suggest CRBP-1 screening as a target to ensure efficacy of an adjuvant retinoid therapy.

KW - Apoptosis

KW - Gynecological cancer

KW - Ovarian tumor

KW - Retinol

KW - Retinol binding protein

UR - http://www.scopus.com/inward/record.url?scp=84906314069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906314069&partnerID=8YFLogxK

M3 - Article

C2 - 24982334

AN - SCOPUS:84906314069

VL - 34

SP - 3303

EP - 3312

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -